Evidence map›Paper›PMID 35808300›Full record

ArticleSensors (Basel, Switzerland)2022

Machine Learning-Based Risk Stratification for Gestational Diabetes Management.

Jenny Yang, David Clifton, Jane E Hirst, Foteini K Kavvoura, George Farah, Lucy Mackillop, Huiqi Lu

Open access · goldAbstract read
In one paragraph

Article in Sensors (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Journal of clinical medicine · 2025
    Review
  6. Artificial Intelligence in Gestational Diabetes Care: A Systematic Review.Journal of diabetes science and technology · 2025
    Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Machine learning and disease prediction in obstetrics.Current research in physiology · 2023
    Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Jenny YangDepartment of Engineering Science, Institute of Biomedical Engineering, University of Oxford, Oxford OX3 7SQ, UK.ORCID 0000-0003-0352-8452
David CliftonDepartment of Engineering Science, Institute of Biomedical Engineering, University of Oxford, Oxford OX3 7SQ, UK.
Jane E HirstNuffield Department of Women's & Reproductive Health, University of Oxford, Oxford OX3 9DU, UK.ORCID 0000-0002-0176-2651
Foteini K KavvouraCentre for Diabetes & Endocrinology, Royal Berkshire Hospitals NHS Foundation Trust, Reading RG1 5BS, UK.ORCID 0000-0002-7021-1191
George FarahCentre for Diabetes & Endocrinology, Royal Berkshire Hospitals NHS Foundation Trust, Reading RG1 5BS, UK.
Lucy MackillopNuffield Department of Women's & Reproductive Health, University of Oxford, Oxford OX3 9DU, UK.ORCID 0000-0002-1927-1594
Huiqi LuDepartment of Engineering Science, Institute of Biomedical Engineering, University of Oxford, Oxford OX3 7SQ, UK.ORCID 0000-0002-6140-3394
University of Oxford · GBRoyal Berkshire Hospital · GBJohn Radcliffe Hospital · GBThe George Institute for Global Health · GB

Funding

Engineering and Physical Sciences Research Council EP/N020774/1European Union's Horizon 2020 research and innovation programme 955681John Fell Fund University of Oxford 0011028Medical Research Council MR/T040750/1Royal Academy of Engineering DJT Fellowship
6 · The paper itself

Abstract

Gestational diabetes mellitus (GDM) is often diagnosed during the last trimester of pregnancy, leaving only a short timeframe for intervention. However, appropriate assessment, management, and treatment have been shown to reduce the complications of GDM. This study introduces a machine learning-based stratification system for identifying patients at risk of exhibiting high blood glucose levels, based on daily blood glucose measurements and electronic health record (EHR) data from GDM patients. We internally trained and validated our model on a cohort of 1148 pregnancies at Oxford University Hospitals NHS Foundation Trust (OUH), and performed external validation on 709 patients from Royal Berkshire Hospital NHS Foundation Trust (RBH). We trained linear and non-linear tree-based regression models to predict the proportion of high-readings (readings above the UK's National Institute for Health and Care Excellence [NICE] guideline) a patient may exhibit in upcoming days, and found that XGBoost achieved the highest performance during internal validation (0.021 [CI 0.019-0.023], 0.482 [0.442-0.516], and 0.112 [0.109-0.116], for MSE, R2, MAE, respectively). The model also performed similarly during external validation, suggesting that our method is generalizable across different cohorts of GDM patients.

Indexed as

Diabetes, GestationalBlood GlucoseFemaleHumansMachine LearningPregnancyPregnancy Trimester, ThirdRisk AssessmentBlood Glucoseblood glucoseclinical decision makingelectronic health recordgestational diabetesmachine learningpatient monitoring

Identifiers

PMID35808300
PMCPMC9268930
OpenAlexW4283575514

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.